Charles Schwab Investment Management Inc Capricor Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 120,285 shares of CAPR stock, worth $773,432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,285
Previous 113,650
5.84%
Holding current value
$773,432
Previous $1.08 Million
10.76%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CAPR
# of Institutions
140Shares Held
12.3MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$14.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$10.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$9.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$6.19 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$3.54 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $157M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...